Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells

Human Immunology

Volumn 71, Issue 3, 2010, Pages 255-262

  Yang, Jing Yue ^a   Cao, Da Yong ^a   Xue, Yan ^a   Yu, Zhao Cai ^a   Liu, Wen Chao ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alpha fetoprotein; Cytotoxic T lymphocytes; Dendritic cells; HBsAg; Immunotherapy

Indexed keywords

ADENOVIRUS VECTOR; ALPHA FETOPROTEIN; DENDRITIC CELL VACCINE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HLA ANTIGEN; INTERLEUKIN 12P70; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER GENE THERAPY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG EFFICACY; FEMALE; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MIXED INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY; VIRAL GENE DELIVERY SYSTEM;

ALPHA-FETOPROTEINS; ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CARCINOMA, HEPATOCELLULAR; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; GENETIC ENGINEERING; HEP G2 CELLS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HLA ANTIGENS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P40; K562 CELLS; LIVER NEOPLASMS; MICE; MICE, SCID;

EID: 76949102305     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.12.010     Document Type: Article

References (38)

1. Lai E.C., and Lau W.Y. The continuing challenge of hepatic cancer in Asia. Surgery 3 (2005) 210-215
2. Lehman E.M., and Wilson M.L. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: A systematic review and meta-analysis. Int J Cancer 124 (2009) 690-697
3. Merican I., Guan R., Amarapuka D., et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 15 (2000) 1356-1361
4. Ibrahim S.M., Lewandowski R.J., Sato K.T., et al. Radioembolization for the treatment of unresectable hepatocellular carcinoma: A clinical review. World J Gastroenterol 14 (2008) 1664-1669
5. Cohen S., Haimovich J., and Hollander N. Dendritic cell-based therapeutic vaccination against myeloma: vaccine formulation determines efficacy against light chain myeloma. J Immunol 182 (2009) 1667-1673
6. Celluzzi C.M., Mayordomo J.I., Storkus W.J., et al. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med 183 (1996) 283-287
7. + cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: A phase I trial [clinical protocol]. Hum Gene Ther 14 (2003) 1347-1360
8. Dubsky P., Ueno H., Piqueras B., et al. Human dendritic cell subsets for vaccination. J Clin Immunol 25 (2005) 551-572
9. - mediated T-cell response from hepatocellular carcinoma patients in vitro. Hum Immunol 68 (2007) 334-341
10. Lapteva N., Aldrich M., Weksberg D., et al. Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity. J Immunother 32 (2009) 145-156
11. Chen L., Tang X.D., Yu S.T., et al. Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice. J Pathol 217 (2009) 685-692
12. Buchsel P.C., and DeMeyer E.S. Dendritic cells: Emerging roles in tumor immunotherapy. Clin J Oncol Nurs 10 (2006) 629-640
13. Ding F.X., Wang F., Lu Y.M., et al. Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma. J Hepatol 49 (2009) 1492-1502
14. Grünebach F., Kayser K., Weck M.M., et al. Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes. Cancer Gene Ther 12 (2005) 749-756
15. Fukushima S., Hirata S., Motomura Y., et al. Multiple Antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells. J Immunother 32 (2009) 219-231
16. Shojaeian J., Jeddi-Tehrani M., Dokouhaki P., et al. Mutual helper effect in copulsing of dendritic cells with 2 antigens: A novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously. J Immunother 32 (2009) 325-332
17. Butterfield L.H., Ribas A., Potter D.M., et al. Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer. Cancer Immunol Immunother 56 (2007) 1931-1943
18. Evdokimova V.N., and Butterfield L.H. Alpha-fetoprotein and other tumour associated antigens for immunotherapy of hepatocellular cancer. Expert Opin Biol Ther 8 (2008) 325-336
19. Ovali E., Dikmen T., Sonmez M., Yilmaz M., Unal A., Dalbasti T., et al. Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: A safety study. J Exp Clin Cancer Res 26 (2007) 209-214
20. Figdor C.G., De Vries I.J., Lesterhuis W.J., et al. Dendritic cell immunotherapy: mapping the way. Nat Med 10 (2004) 475-480
21. Koya R.C., Weber J.S., Kasahara N., et al. Making dendritic cells from the inside out: Lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14t monocytes generates dendritic cells in vitro. Hum Gene Ther 15 (2004) 733-748
22. Liu Y., Chiriva-Internati M., Grizzi F., et al. Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector. Cancer Gene Ther 8 (2001) 948-957
23. Asemissen A.M., and Brossart P. Vaccination strategies in patients with renal cell carcinoma. Cancer Immunol Immunother 58 (2009) 1169-1174
24. Timares L., Douglas J.T., Tillman B.W., et al. Adenovirus-mediated gene delivery to dendritic cells. Methods Mol Biol 246 (2004) 139-154
25. Chiriva-Internati M., Liu Y., Salati E., et al. Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells. Eur J Immunol 32 (2002) 30-38
26. Motta I., Andre F., Lim A., et al. Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells. J Immunol 167 (2001) 1795-1802
27. Diebold S.S., Cotton M., Koch N., et al. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells. Gene Ther 8 (2001) 487-493
28. Lee J.M., Mahtabifard A., Yamada R., et al. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor κB cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors. Clin Cancer Res 8 (2002) 3561
29. Bubenik J. Genetically engineered dendritic cell-based cancer vaccines. Int J Oncol 18 (2001) 475-478
30. Moll H. Antigen delivery by dendritic cells. Int J Med Microbiol 294 (2004) 337-344
31. + T-cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients. Clin Cancer Res 11 (2005) 6686-6694
32. Mizukoshi E., Nakamoto Y., Tsuji H., et al. Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma. Int J Cancer 118 (2006) 1194-1204
33. Um S.H., Mulhall C., Alisa A., et al. Alpha-fetoprotein impairs APC function and induces their apoptosis. J Immunol 173 (2004) 1772-1778
34. Guo J., Cai M., Wei D., et al. Immune responses of dendritic cells after loaded with cytotoxicity T lymphocyte epitope based peptide of human alpha-fetoprotein (hAFP). Zhonghua Ganzangbing Zazhi 10 (2002) 178-180
35. Fazle Akbar S.M., Furukawa S., Yoshida O., et al. Induction of anti-HBs in HB vaccine nonresponders in vivo by hepatitis B surface antigen-pulsed blood dendritic cells. J Hepatol 47 (2007) 60-66
36. Shi M., Qian S., Chen W.W., et al. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro. Clin Exp Immunol 147 (2007) 277-286
37. + T cell subsets. Int Immunol 19 (2007) 1191-1199
38. Bajaña S., Herrera-González N., Narváez J., et al. Differential CD4(+) T-cell memory responses induced by two subsets of human monocyte-derived dendritic cells. Immunology 122 (2007) 381-393